Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NYSE
Amneal Pharmaceuticals Holding Co (AMRX)
Amneal Pharmaceuticals Holding Co (AMRX) News

AMRX

Amneal Pharmaceuticals (AMRX)

Amneal Pharmaceuticals Holding Co

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:AMRX

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
09/05/2024	4:05PM	Business Wire	Amneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administration	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
08/20/2024	11:26AM	Business Wire	Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
08/20/2024	8:00AM	Business Wire	Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
08/14/2024	3:12PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
08/14/2024	11:04AM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
08/14/2024	5:56AM	IH Market News	UBS Beats Earnings Forecasts, Intel Divests Arm Holdings, Flutter Surges 9% in Premarket Trading, and More	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
08/09/2024	6:05AM	Business Wire	Amneal Reports Second Quarter 2024 Financial Results	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
08/07/2024	4:45PM	Business Wire	Amneal Receives U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease to Be Launched as CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
07/29/2024	4:05PM	Business Wire	Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
07/11/2024	4:05PM	Business Wire	Amneal to Report Second Quarter 2024 Results on August 9, 2024	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
07/09/2024	4:05PM	Business Wire	Amneal Launches FOCINVEZ™, the First Ready-to-Use Version of Fosaprepitant	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
07/01/2024	8:00AM	Business Wire	Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
07/01/2024	8:00AM	Business Wire	Amneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab Biosimilar	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
06/28/2024	8:00AM	Business Wire	Amneal Releases 2023 Environmental, Social and Governance Report	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
06/05/2024	8:00AM	Business Wire	Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/22/2024	4:05PM	Business Wire	Amneal to Participate at Upcoming Investor Conference	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/22/2024	4:05PM	Business Wire	Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/16/2024	3:13PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/16/2024	3:13PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/14/2024	4:45PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/14/2024	4:45PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/14/2024	4:43PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/14/2024	4:42PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/07/2024	4:18PM	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/06/2024	5:35PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/06/2024	5:31PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/06/2024	5:28PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/06/2024	5:19PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/06/2024	5:17PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMRX	Amneal Pharmaceuticals Holding Co
05/03/2024	6:14AM	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AMRX	Amneal Pharmaceuticals Holding Co

Showing the most relevant articles for your search:NYSE:AMRX

1 2 3 4 5 6 7 8 9 10 Next >>

Cassava Sciences

Enanta Pharmaceuticals

Moon Equity (PK)

Anavex Life Sciences

Digital Brand Media and ... (PK)

AMC Entertainment

Brookmount Explorations (PK)

Global Developments (PK)

ERHC Energy (CE)

Kraig Biocraft Laborator... (QB)

Sincerity Applied Materi... (PK)

Good Vibrations Shoes (PK)

NioCorp Developments

Lightwave Logic

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions